Faster access than browser!Similarities between Osteoporosis and Tamoxifen
Osteoporosis and Tamoxifen have 14 things in common (in Unionpedia): Aromatase inhibitor, Breast cancer, Cancer, Deep vein thrombosis, Developing country, Estrogen receptor, Menopause, Osteoclast, Pulmonary embolism, Raloxifene, Selective serotonin reuptake inhibitor, Stroke, Testosterone, Venous thrombosis.
Aromatase inhibitor
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and gynecomastia in men.
Aromatase inhibitor and Osteoporosis · Aromatase inhibitor and Tamoxifen ·
Breast cancer
Breast cancer is cancer that develops from breast tissue.
Breast cancer and Osteoporosis · Breast cancer and Tamoxifen ·
Cancer
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
Cancer and Osteoporosis · Cancer and Tamoxifen ·
Deep vein thrombosis
Deep vein thrombosis (DVT), is the formation of a blood clot in a deep vein, most commonly the legs.
Deep vein thrombosis and Osteoporosis · Deep vein thrombosis and Tamoxifen ·
Developing country
A developing country (or a low and middle income country (LMIC), less developed country, less economically developed country (LEDC), underdeveloped country) is a country with a less developed industrial base and a low Human Development Index (HDI) relative to other countries.
Developing country and Osteoporosis · Developing country and Tamoxifen ·
Estrogen receptor
Estrogen receptors (ERs) are a group of proteins found inside cells.
Estrogen receptor and Osteoporosis · Estrogen receptor and Tamoxifen ·
Menopause
Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children.
Menopause and Osteoporosis · Menopause and Tamoxifen ·
Osteoclast
An osteoclast is a type of bone cell that breaks down bone tissue.
Osteoclast and Osteoporosis · Osteoclast and Tamoxifen ·
Pulmonary embolism
Pulmonary embolism (PE) is a blockage of an artery in the lungs by a substance that has moved from elsewhere in the body through the bloodstream (embolism).
Osteoporosis and Pulmonary embolism · Pulmonary embolism and Tamoxifen ·
Raloxifene
Raloxifene, developed by Eli Lilly in 1997 and sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.
Osteoporosis and Raloxifene · Raloxifene and Tamoxifen ·
Selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder and anxiety disorders.
Osteoporosis and Selective serotonin reuptake inhibitor · Selective serotonin reuptake inhibitor and Tamoxifen ·
Stroke
A stroke is a medical condition in which poor blood flow to the brain results in cell death.
Osteoporosis and Stroke · Stroke and Tamoxifen ·
Testosterone
Testosterone is the primary male sex hormone and an anabolic steroid.
Osteoporosis and Testosterone · Tamoxifen and Testosterone ·
Venous thrombosis
A venous thrombus is a blood clot (thrombus) that forms within a vein.
Osteoporosis and Venous thrombosis · Tamoxifen and Venous thrombosis ·
The list above answers the following questions
- What Osteoporosis and Tamoxifen have in common
- What are the similarities between Osteoporosis and Tamoxifen
Osteoporosis and Tamoxifen Comparison
Osteoporosis has 250 relations, while Tamoxifen has 111. As they have in common 14, the Jaccard index is 3.88% = 14 / (250 + 111).
References
This article shows the relationship between Osteoporosis and Tamoxifen. To access each article from which the information was extracted, please visit:
